What Is the UroLift® System?

Treatment with the UroLift® System is a proven treatment that provides rapid relief and recovery for men living with symptoms of an enlarged prostate.1 It can break the cycle of medications and how they make a person feel with fewer risks than traditional surgery.2 The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.
Homem mais velho sentado ao lado da cama em frustração

Most men living with enlarged prostate (BPH) symptoms take prescription medications after they’re diagnosed but these prescriptions often don’t provide adequate relief and may cause dizziness, fatigue, and sexual dysfunction.2 Medications don't need to become a lifelong burden and men don’t need to wait until surgery is required to address the problem. With the UroLift System treatment, men suffering from BPH symptoms can avoid traditional surgery.

What is BPH?     Visit Our FAQ Page

There’s a proven option that can help men feel revitalised without having to compromise: The UroLift System treatment a proven solution to treat the blockage, freeing men from ongoing BPH medications with a rapid recovery.1

The UroLift System     Visit Our FAQ Page
Casal dançando em um quarto ensolarado

A Minimally Invasive Treatment for BPH

Treatment with the UroLift System is usually done on a day case basis or as an outpatient treatment; small implants are used to keep the blocked pathway that impedes the flow of urine open, so that the blockage is addressed and the symptoms of the enlarged prostate (BPH) do not have to be treated all the time. Most patients can return home immediately and experience a speedy recovery.1
Próstata aumentada bloqueando a ilustração da uretra

Enlarged Prostate

An enlarged prostate can narrow or even block the urethra.

UroLift Passo 1 Ilustração do Procedimento

Step 1

The UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.

UroLift Passo 2 Ilustração do Procedimento

Step 2

Small UroLift Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.

UroLift Passo 3 Ilustração do Procedimento

Step 3

The UroLift System treatment provides fast and reliable symptom relief by opening the obstructed urethra.1

Why the UroLift System?

The UroLift System provides a proven treatment that can get men off BPH medications which can make a person feel foggy and cause sexual dysfunction.1,2 Treatment with the UroLift System has a favorable risk profile when compared to traditional BPH surgical procedures that may have serious complications and a long, painful recovery.2,5,7  The treatment may be right for you if any of the following apply:
You want a BPH solution that preserves your sexual function*
You do not want to take a pill for BPH
You tried BPH medication and are unhappy with the side effects
You do not want to undergo major surgery due to risks of complications and side effects
You want to regain your quality of life with limited downtime
You want a minimally invasive treatment that can be performed in your doctor's office
Casal dançando em um telhado contra um pôr do sol

For Patients

Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. Over 70% of men in their 60s have BPH symptoms, so it is very common6. While BPH is a benign condition, unrelated to prostate cancer, it can greatly affect quality of life.

Learn More

Médico e paciente falando em consulta

For Physicians

The UroLift System is an early treatment option for BPH. It is the only leading enlarged prostate procedure that does not require heating, cutting, removal or destruction of prostate tissue - delivering rapid symptom relief and recovery2, 7-11

Learn More

Source Information

  1. Roehrborn et al. Can J Urol 2017
  2. AUA Guidelines 2003, 2020
  3. Wasson, Perspectives in Nursing 2000
  4. NIH U.S. National Library of Medicine – TURP patient instructions https://medlineplus.gov/ency/patientinstructions/000300.htm
  5. Sonksen, EU Urol, 2015 BPH6 Study
  6. Berry et al, J Urol 1984
  7. Roehrborn, J Urol 2013
  8. Mirakhur, Can Assoc Rad J 2017
  9. McVary, J Urol 2016
  10. Gilling, Can J Urol 2020
  11. Kadner, World J Urol 2020

 *No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T pivotal

INFORMATION FOR PATIENTS ABOUT THE UROLIFT® SYSTEM

The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH), available for men 50 years or older with an enlarged prostate up to 100 cc who are looking for an alternative to drugs or major surgeries.
 

The UroLift System’s implants, which can be delivered during an outpatient procedure, relieve prostate obstruction without heating, cutting, destruction of, or removing prostate tissue.

The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.1 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.*2-4

Most common side effects are temporary and can include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.5 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.

Treatment using the UroLift System is not appropriate if you have a prostate volume greater than 100cc, a urinary tract infection or other conditions that can be identified by your urologist.

Individual results with the UroLift System may vary.

WARNINGS:
1) THE UROLIFT SYSTEM’S IMPLANTS ARE PERMANENT (THAT IS TO SAY: ONCE IMPLANTED, THEY CANNOT BE COMPLETELY REMOVED).

2) THE UROLIFT SYSTEM’S IMPLANTS CONTAIN STAINLESS STEEL AND NITINOL, AN ALLOY OF NICKEL AND TITANIUM. INDIVIDUALS WHO ARE ALLERGIC TO THESE METALS MAY SUFFER AN ALLERGIC REACTION TO THE IMPLANT. PRIOR TO HAVING A UROLIFT SYSTEM PROCEDURE, YOU SHOULD DISCUSS ANY ALLERGY/HYPERSENSITIVITY TO THESE MATERIALS WITH YOUR UROLOGIST.

3) THE ABOVEMENTIONED INFORMATION IS NOT INTENDED TO PROVIDE MEDICAL ADVICE TO PATIENTS OR TO REPLACE THEIR DOCTORS' EXPERT OPINION AND CARE.

4) ONLY A DOCTOR CAN DIAGNOSE WHETHER HIS/HER PATIENT HAS BPH, ASSESS HIS INDIVIDUAL CONDITION AND DEFINE WHETHER UROLIFT SYSTEM IS THE ADEQUATE TREATMENT OR NOT.

5) TALK TO YOUR UROLOGIST FOR MORE INFORMATION ABOUT THE UROLIFT SYSTEM AND TO DETERMINE IF IT IS THE RIGHT TREATMENT FOR YOU.

*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.

  1. Rukstalis, Prostate Cancer and Prostatic Dis 2018
  2. Roehrborn, Can J Urol 2017
  3. AUA BPH Guidelines 2003, 2020
  4. McVary, J Sex Med 2016
  5. Roehrborn, J Urology 2013

INFORMATION FOR PHYSICIANS ABOUT THE UROLIFT® SYSTEM

The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It is indicated for the treatment of symptoms of an enlarged prostate up to 100 cc in men 50 years or older. The UroLift implants are permanent and can be delivered during an outpatient procedure, relieving prostate obstruction without heating, cutting, destructing, or removing prostate tissue. The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.1 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.*2-4 Most common side effects are temporary and can include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence.5 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Individual results may vary. The prostatic urethral lift procedure (using the UroLift System) is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines.
 
Contraindicated in men with a prostate volume greater than 100cc or a urinary tract infection.
 
Warning: This device contains stainless steel and nitinol, an alloy of nickel and titanium. Persons with allergic reactions to these metals may suffer an allergic reaction to this implant. Prior to implantation, patients should be counseled on the materials contained in the device, as well as potential for allergy/hypersensitivity to these materials.

Individual results may vary. For full information, please consult the Instructions for Use (IFU)

*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.

  1. Rukstalis, Prostate Cancer and Prostatic Dis 2018
  2. Roehrborn, Can J Urol 2017
  3. AUA BPH Guidelines 2003, 2020
  4. McVary, J Sex Med 2016
  5. Roehrborn, J Urology 2013

 

Teleflex, BPH Relief In Sight and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. ©2023 Teleflex Incorporated. All rights reserved. Revised: 02/2023. MC-008657 LA EN

Teleflex Medical Brasil Ltda
Rua Alexandre Dumas, 2100/132 - Chacara Santo Antonio
São Paulo/SP - CEP 04717-913